<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04621396</url>
  </required_header>
  <id_info>
    <org_study_id>H2013:227</org_study_id>
    <nct_id>NCT04621396</nct_id>
  </id_info>
  <brief_title>The Next Generation Longitudinal Birth Cohort Diabetes Study</brief_title>
  <acronym>NextGen</acronym>
  <official_title>Genetic and Environmental Influences on Development of Type 2 Diabetes in Childhood: The Next Generation Longitudinal Birth Cohort.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim of this project is to understand the independent roles of maternal factors,&#xD;
      intrauterine exposures, genetic factors, and postnatal environment on the development of&#xD;
      obesity and youth-onset type 2 diabetes (T2D) in childhood.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our primary objective for the study is to clinically and metabolically phenotype parents and&#xD;
      their offspring to identify risk factors for obesity, T2D, and cardiometabolic risk in&#xD;
      childhood and adolescence in a prospective birth cohort by reporting:&#xD;
&#xD;
        1. Maternal and/or paternal factors including anthropometrics, metabolic parameters, HNF1a&#xD;
           genotype, lifestyle (diet and physical activity), and socioeconomic environment.&#xD;
&#xD;
        2. Infant factors including anthropometrics, early infant nutrition, and metabolism.&#xD;
&#xD;
      Secondary Objectives:&#xD;
&#xD;
        1. To evaluate if children born to mothers with T2D prior o pregnancy are at increased risk&#xD;
           of obesity and T2D.&#xD;
&#xD;
        2. To determine the modifiable risk factors which contribute to the increased risk of&#xD;
           obesity and T2D.&#xD;
&#xD;
        3. To evaluate the differential risk between mothers and fathers with T2D in terms of&#xD;
           somatic and genetic contributions to risk compared to intrauterine environmental&#xD;
           contributions to risk.&#xD;
&#xD;
        4. To plan a large-scale, randomized, controlled community-based breastfeeding intervention&#xD;
           with intensive breastfeeding counseling and support for the prevention of T2D&#xD;
           development in offspring of mothers or fathers with youth onset T2D.&#xD;
&#xD;
        5. To explore potential new research questions and feasibility studies for epigenetic&#xD;
           studies using cord blood under the umbrella of the new research theme on T2D at the&#xD;
           Children's Hospital Research Institute of Manitoba.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2013</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Obesity</measure>
    <time_frame>18 years</time_frame>
    <description>Development of obesity defined by the International task force on obesity cut offs for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Type 2 Diabetes</measure>
    <time_frame>18 years</time_frame>
    <description>Development of type 2 diabetes defined by diagnostic criteria in the Canadian Diabetes association 2008 guidelines in childhood (≤ 7 years) or adolescence (12-16 years).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Gestational Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Next Generation Cohort</arm_group_label>
    <description>We will follow the children from mothers who either have T2D, GDM, or are controls.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational screening study</intervention_name>
    <arm_group_label>Next Generation Cohort</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      For pregnant women: hemoglobin A1C, fasting lipid panel, adiponectin, leptin, apolipoprotein&#xD;
      A and B, AST, and ALT, and HNF1a carrier status.&#xD;
&#xD;
      At birth: In offspring: HNF1a status, apolipoprotein A and B, glucose, insulin, c-peptide,&#xD;
      and free fatty acid, leptin, and adiponectin, c-reactive protein (CRP), cytokines&#xD;
      (interleukins and TNF alpha) will be tested on cord blood.&#xD;
&#xD;
      age 1 to18 - creatine, albumin measurements, and urinalysis. Also, starting at age 6 and&#xD;
      every 2 years afterward, urine will be frozen to test for biomarkers that may predict kidney&#xD;
      damage or uncover causes for kidney damage in the future.&#xD;
&#xD;
      age 7 to 18 - hemoglobin A1C, blood glucose levels, insulin levels, apolipoprotein A and B,&#xD;
      c-reactive protein, lipoprotein profile, ALT, AST, leptin, and adiponectin.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children between the age of 0 and 18 or until a diagnosis of type 2 diabetes.&#xD;
&#xD;
        Diagnosis of diabetes will be made according to the Canadian Diabetes Association criteria.&#xD;
        There must be 2 abnormal blood glucose tests on different days OR 1 abnormal blood glucose&#xD;
        test + symptoms of diabetes:&#xD;
&#xD;
        Fasting plasma glucose of &gt; 7.0 mmol/L or Random glucose &gt; 11.1mmol/L or 2-hour glucose &gt;&#xD;
        11.1 mmol/L after a standard oral glucose tolerance test (75g).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women with type 2 diabetes, gestational diabetes, or no diabetes.&#xD;
&#xD;
          -  From self-identified Indigenous heritage (e.g., Cree, Oji-Cree, Métis, Anishinaabe,&#xD;
             etc.).&#xD;
&#xD;
          -  Are delivering and residing in Manitoba.&#xD;
&#xD;
          -  Mother/Father and children must be biological family members.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Mothers or children with type 1 diabetes.&#xD;
&#xD;
          -  Residing outside of Manitoba.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Brandy A Wicklow, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba, Children's Hospital Research Institute of Manitoba</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brandy A Wicklow, MD, MSc</last_name>
    <phone>204-787-1222</phone>
    <email>bwicklow@hsc.mb.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elizabeth AC Sellers, MD, MSc</last_name>
    <phone>204-787-3011</phone>
    <email>esellers@hsc.mb.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Research Institute of Manitoba/University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 3P4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandy A Wicklow, MD, MSc</last_name>
      <phone>204781222</phone>
      <email>bwicklow@hsc.mb.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>https://www.dreamdiabetesresearch.com/</url>
    <description>Website that has all the current projects that deal with diabetes.</description>
  </link>
  <reference>
    <citation>Mendelson M, Cloutier J, Spence L, Sellers E, Taback S, Dean H. Obesity and type 2 diabetes mellitus in a birth cohort of First Nation children born to mothers with pediatric-onset type 2 diabetes. Pediatr Diabetes. 2011 May;12(3 Pt 2):219-28. doi: 10.1111/j.1399-5448.2010.00694.x. Epub 2011 Mar 23.</citation>
    <PMID>21429061</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 3, 2020</study_first_submitted>
  <study_first_submitted_qc>November 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manitoba</investigator_affiliation>
    <investigator_full_name>Dr. Brandy Wicklow</investigator_full_name>
    <investigator_title>Assistant Professor, Pediatrics and Child Health</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

